Table 1 Patient characteristics
Patients N=121 | Number (%) |
|---|---|
Age in years median (range) ≤65 years >65 years | 62 (26-89) 77 (64%) 44 (36%) |
Sex | |
Male Female | 74 (61%) 47 (39%) |
Primary diagnosis | |
Glioblastoma Astrocytoma Oligodendroglioma Oligoastrocytoma Others or no histological diagnosis | 92 (76%) 10 (8%) 5 (4%) 8 (7%) 6 (5%) |
Surgical interventions | |
Operation Biopsy No operation or biopsy | 108 (89%) 11 (9%) 2 (2%) |
Primary treatment with curative or life prolonging intent | |
Chemoradiotherapy and adjuvant chemotherapy Chemoradiotherapy Radiotherapy and adjuvant chemotherapy Radiotherapy Chemotherapy Palliative radiotherapy Supportive care only | 62 (51%) 17 (14%) 3 (2%) 21 (17%) 2 (2%) 10 (8%) 6 (5%) |
Systemic anticancer treatments after primary treatment | |
1st line 2nd line 3rd line or more | 28 (23%) 20 (17%) 14 (12%) |
Re-irradiation courses after primary treatment | |
One Two Three or more | 43 (36%) 9 (7%) 1 (1%) |
Median survival (time and range) | |
After diagnosis Glioblastoma Other histology After PC decision Glioblastoma Other histology | 16 months (1-238) 13 months (1-95) 51 months (2-238) 44 days (1-293) 38 days (0-270) 71 days (1-293) |